Effect of Probiotics on Infant's Fecal Microbiota Composition - Trial NCT05524649
Access comprehensive clinical trial information for NCT05524649 through Pure Global AI's free database. This phase not specified trial is sponsored by AB Biotics, SA and is currently Recruiting. The study focuses on Microbial Colonization. Target enrollment is 120 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
AB Biotics, SA
Timeline & Enrollment
N/A
Jun 01, 2022
Dec 31, 2023
Primary Outcome
Change of Bifidobacterium longum and Pediococcus pentosaceus in feces
Summary
Randomized clinical trial to evaluate the effect of two probiotic strains which belong to
 Bifidobacterium Longum and Pediococcus pentosaceus species on fecal microbiota composition in
 healthy infants. Secondary outcomes comprise evaluation of anthropometric growth, digestive
 tolerance, sleeping habits, incidence of functional gastrointestinal disorders, incidence of
 gastrointestinal and respiratory infections, allergic reactions and safety and tolerability
 of the product.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05524649
Non-Device Trial